Search
Menu
Home
HTB
2024
November
HTB
November 2024
Contents
Editorial
HTB news: i-Base changes during 2024
Special reports
Unheard: The medical practice of silencing – by Dr Rageshri Dhairyawan
Conference reports
Glasgow HIV Congress 2024: Introduction and links
Once-weekly oral ART with islatravir plus lenacapavir sustains results to week 48
EACS guidelines: New format and contents includes chemsex
Double dose start for oral PrEP in new EACS guidelines – rapid protection in two hours
Future PrEP and new results from PURPOSE 1 and 2 – does HIV exposure explain incident cases?
Liverpool University Drug Interaction website recognised for global impact on research and care
HCV coinfection approaches zero in Spain: but cirrhosis and reinfection among gay men are still significant even with high rates of cure
Dolutegravir/lamivudine vs triple ART have similar efficacy in advanced HIV infection with CD4 <200 and viral load >100,000
Treatment access
Management of drug resistance to integrase inhibitors: results from an international perinatal virtual clinic
mpox (monkeypox)
Mpox breakthrough cases after two doses of the MVA-BN vaccine
Coinfections and complications
Bipolar disorder in people living with HIV
On the web
WHO toolkit to strengthen engagement of health workers in emergency responses
HTB RSS
Early access
Updated treatment guides
5 December 2024
All early access reports
Current issues
December 2024
November 2024
October 2024
Back issues
Special report
Unheard: The medical practice of silencing – by Dr Rageshri Dhairyawan
9 November 2024
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate